PHODACO

Drug name: PHODACO
Generic Name: Dacomitinib
Dosage form: Tablets Dosage: 45 mg oral, once daily Packaging: 15 mg tablets: 30 tablets/bottle Category: Tumor Indications: First-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletion mutation or exon 21 L858R substitution mutation Approval number: 01 L 0839/21